nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—PTGS1—ulcerative colitis	0.303	0.673	CbGaD
Candesartan—ABCB1—ulcerative colitis	0.147	0.327	CbGaD
Candesartan—PTGS1—Olsalazine—ulcerative colitis	0.086	0.195	CbGbCtD
Candesartan—PTGS1—Balsalazide—ulcerative colitis	0.0766	0.174	CbGbCtD
Candesartan—PTGS1—Mesalazine—ulcerative colitis	0.0613	0.139	CbGbCtD
Candesartan—PTGS1—Sulfasalazine—ulcerative colitis	0.0342	0.0776	CbGbCtD
Candesartan—CYP2C8—Nicotine—ulcerative colitis	0.0254	0.0576	CbGbCtD
Candesartan—CYP2C8—Cholecalciferol—ulcerative colitis	0.0228	0.0517	CbGbCtD
Candesartan—CYP2C9—Nicotine—ulcerative colitis	0.0177	0.0402	CbGbCtD
Candesartan—ABCB1—Methylprednisolone—ulcerative colitis	0.0176	0.04	CbGbCtD
Candesartan—CYP2C9—Cholecalciferol—ulcerative colitis	0.0159	0.036	CbGbCtD
Candesartan—CYP2C8—Hydrocortisone—ulcerative colitis	0.0159	0.036	CbGbCtD
Candesartan—ABCB1—Betamethasone—ulcerative colitis	0.0115	0.026	CbGbCtD
Candesartan—ABCB1—Prednisolone—ulcerative colitis	0.0113	0.0257	CbGbCtD
Candesartan—ABCB1—Hydrocortisone—ulcerative colitis	0.0107	0.0243	CbGbCtD
Candesartan—ABCB1—Prednisone—ulcerative colitis	0.0107	0.0242	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—ulcerative colitis	0.00986	0.0224	CbGbCtD
Candesartan—CYP2C9—Dexamethasone—ulcerative colitis	0.00688	0.0156	CbGbCtD
Candesartan—ABCB1—Dexamethasone—ulcerative colitis	0.00667	0.0151	CbGbCtD
Candesartan—Pranlukast—MUC2—ulcerative colitis	0.00271	0.453	CrCbGaD
Candesartan—Pranlukast—NFKB1—ulcerative colitis	0.00161	0.269	CrCbGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.0012	0.0637	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—MICA—ulcerative colitis	0.000975	0.0515	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—SLC39A11—ulcerative colitis	0.000649	0.0343	CbGpPWpGaD
Candesartan—Pranlukast—TNF—ulcerative colitis	0.000495	0.0826	CrCbGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000445	0.0235	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CXCR1—ulcerative colitis	0.000433	0.0229	CbGpPWpGaD
Candesartan—Telmisartan—PPARG—ulcerative colitis	0.000427	0.0712	CrCbGaD
Candesartan—AGTR1—Arf6 signaling events—ADRB2—ulcerative colitis	0.000387	0.0205	CbGpPWpGaD
Candesartan—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00035	0.0185	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000348	0.0184	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CXCR2—ulcerative colitis	0.000339	0.0179	CbGpPWpGaD
Candesartan—AGTR1—Peptide GPCRs—CCR6—ulcerative colitis	0.000319	0.0168	CbGpPWpGaD
Candesartan—AGTR1—Arf6 trafficking events—ADRB2—ulcerative colitis	0.000306	0.0162	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000301	0.0159	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000286	0.0151	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL17A—ulcerative colitis	0.000262	0.0139	CbGpPWpGaD
Candesartan—Irbesartan—PTGS1—ulcerative colitis	0.000254	0.0424	CrCbGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.000248	0.0131	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000244	0.0129	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL12B—ulcerative colitis	0.000244	0.0129	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CTLA4—ulcerative colitis	0.000229	0.0121	CbGpPWpGaD
Candesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000209	0.0111	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.000204	0.0108	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000202	0.0107	CbGpPWpGaD
Candesartan—Hypotension—Azathioprine—ulcerative colitis	0.000189	0.00224	CcSEcCtD
Candesartan—Haemorrhage—Prednisolone—ulcerative colitis	0.000189	0.00224	CcSEcCtD
Candesartan—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000185	0.0022	CcSEcCtD
Candesartan—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000185	0.00219	CcSEcCtD
Candesartan—AGTR1—Arf6 trafficking events—CDH1—ulcerative colitis	0.000184	0.00975	CbGpPWpGaD
Candesartan—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000184	0.00218	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000184	0.00218	CcSEcCtD
Candesartan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000184	0.00971	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—ABCB1—ulcerative colitis	0.000184	0.0097	CbGpPWpGaD
Candesartan—Epistaxis—Triamcinolone—ulcerative colitis	0.000182	0.00216	CcSEcCtD
Candesartan—Thrombocytopenia—Mesalazine—ulcerative colitis	0.00018	0.00214	CcSEcCtD
Candesartan—Urticaria—Budesonide—ulcerative colitis	0.00018	0.00213	CcSEcCtD
Candesartan—Tachycardia—Mesalazine—ulcerative colitis	0.00018	0.00213	CcSEcCtD
Candesartan—Body temperature increased—Budesonide—ulcerative colitis	0.000179	0.00212	CcSEcCtD
Candesartan—Abdominal pain—Budesonide—ulcerative colitis	0.000179	0.00212	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000179	0.00945	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL10—ulcerative colitis	0.000178	0.00942	CbGpPWpGaD
Candesartan—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000178	0.00211	CcSEcCtD
Candesartan—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000177	0.0021	CcSEcCtD
Candesartan—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000177	0.0021	CcSEcCtD
Candesartan—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000174	0.00207	CcSEcCtD
Candesartan—Haemoglobin—Triamcinolone—ulcerative colitis	0.000174	0.00207	CcSEcCtD
Candesartan—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000174	0.00206	CcSEcCtD
Candesartan—Rhinitis—Triamcinolone—ulcerative colitis	0.000174	0.00206	CcSEcCtD
Candesartan—Rhinitis—Methylprednisolone—ulcerative colitis	0.000173	0.00206	CcSEcCtD
Candesartan—Haemorrhage—Triamcinolone—ulcerative colitis	0.000173	0.00206	CcSEcCtD
Candesartan—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000173	0.00205	CcSEcCtD
Candesartan—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000173	0.00205	CcSEcCtD
Candesartan—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000173	0.00205	CcSEcCtD
Candesartan—Pharyngitis—Triamcinolone—ulcerative colitis	0.000172	0.00204	CcSEcCtD
Candesartan—Hypotension—Mesalazine—ulcerative colitis	0.000172	0.00204	CcSEcCtD
Candesartan—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000172	0.00204	CcSEcCtD
Candesartan—Myocardial infarction—Betamethasone—ulcerative colitis	0.000172	0.00204	CcSEcCtD
Candesartan—Valsartan—ALB—ulcerative colitis	0.000171	0.0285	CrCbGaD
Candesartan—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000168	0.00199	CcSEcCtD
Candesartan—Sweating increased—Prednisone—ulcerative colitis	0.000167	0.00198	CcSEcCtD
Candesartan—Paraesthesia—Mesalazine—ulcerative colitis	0.000165	0.00196	CcSEcCtD
Candesartan—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000165	0.00196	CcSEcCtD
Candesartan—Dyspnoea—Mesalazine—ulcerative colitis	0.000164	0.00195	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.000164	0.00866	CbGpPWpGaD
Candesartan—Somnolence—Mesalazine—ulcerative colitis	0.000164	0.00194	CcSEcCtD
Candesartan—Asthenia—Budesonide—ulcerative colitis	0.000162	0.00193	CcSEcCtD
Candesartan—Dyspepsia—Mesalazine—ulcerative colitis	0.000162	0.00192	CcSEcCtD
Candesartan—Mental disorder—Hydrocortisone—ulcerative colitis	0.000161	0.00191	CcSEcCtD
Candesartan—Malnutrition—Hydrocortisone—ulcerative colitis	0.00016	0.0019	CcSEcCtD
Candesartan—Neutropenia—Prednisone—ulcerative colitis	0.00016	0.0019	CcSEcCtD
Candesartan—Pruritus—Budesonide—ulcerative colitis	0.00016	0.0019	CcSEcCtD
Candesartan—Abdominal pain—Azathioprine—ulcerative colitis	0.00016	0.00189	CcSEcCtD
Candesartan—Body temperature increased—Azathioprine—ulcerative colitis	0.00016	0.00189	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000159	0.00843	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000159	0.00842	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000159	0.0084	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000159	0.00188	CcSEcCtD
Candesartan—Fatigue—Mesalazine—ulcerative colitis	0.000159	0.00188	CcSEcCtD
Candesartan—Haemoglobin—Dexamethasone—ulcerative colitis	0.000158	0.00188	CcSEcCtD
Candesartan—Haemoglobin—Betamethasone—ulcerative colitis	0.000158	0.00188	CcSEcCtD
Candesartan—Haemorrhage—Dexamethasone—ulcerative colitis	0.000157	0.00187	CcSEcCtD
Candesartan—Haemorrhage—Betamethasone—ulcerative colitis	0.000157	0.00187	CcSEcCtD
Candesartan—Diarrhoea—Budesonide—ulcerative colitis	0.000155	0.00184	CcSEcCtD
Candesartan—Hyperglycaemia—Prednisone—ulcerative colitis	0.000154	0.00183	CcSEcCtD
Candesartan—Telmisartan—ABCB1—ulcerative colitis	0.000153	0.0256	CrCbGaD
Candesartan—Mental disorder—Methylprednisolone—ulcerative colitis	0.000152	0.0018	CcSEcCtD
Candesartan—Malnutrition—Methylprednisolone—ulcerative colitis	0.000151	0.00179	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisone—ulcerative colitis	0.00015	0.00178	CcSEcCtD
Candesartan—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00015	0.00178	CcSEcCtD
Candesartan—Angioedema—Prednisolone—ulcerative colitis	0.00015	0.00178	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00015	0.00792	CbGpPWpGaD
Candesartan—Myocardial infarction—Prednisone—ulcerative colitis	0.00015	0.00177	CcSEcCtD
Candesartan—Dizziness—Budesonide—ulcerative colitis	0.00015	0.00177	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.00015	0.0079	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.000149	0.00788	CbGpPWpGaD
Candesartan—Vertigo—Prednisolone—ulcerative colitis	0.000147	0.00175	CcSEcCtD
Candesartan—Angioedema—Hydrocortisone—ulcerative colitis	0.000146	0.00174	CcSEcCtD
Candesartan—Urticaria—Mesalazine—ulcerative colitis	0.000146	0.00173	CcSEcCtD
Candesartan—Back pain—Triamcinolone—ulcerative colitis	0.000146	0.00173	CcSEcCtD
Candesartan—Abdominal pain—Mesalazine—ulcerative colitis	0.000145	0.00173	CcSEcCtD
Candesartan—Body temperature increased—Mesalazine—ulcerative colitis	0.000145	0.00173	CcSEcCtD
Candesartan—Vertigo—Hydrocortisone—ulcerative colitis	0.000144	0.00171	CcSEcCtD
Candesartan—Vomiting—Budesonide—ulcerative colitis	0.000144	0.00171	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.000143	0.00758	CbGpPWpGaD
Candesartan—Rash—Budesonide—ulcerative colitis	0.000143	0.00169	CcSEcCtD
Candesartan—Dermatitis—Budesonide—ulcerative colitis	0.000142	0.00169	CcSEcCtD
Candesartan—Headache—Budesonide—ulcerative colitis	0.000142	0.00168	CcSEcCtD
Candesartan—Hypertension—Prednisolone—ulcerative colitis	0.000142	0.00168	CcSEcCtD
Candesartan—Hypertension—Hydrocortisone—ulcerative colitis	0.000138	0.00164	CcSEcCtD
Candesartan—Diarrhoea—Azathioprine—ulcerative colitis	0.000138	0.00164	CcSEcCtD
Candesartan—Angioedema—Triamcinolone—ulcerative colitis	0.000138	0.00164	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—ulcerative colitis	0.000138	0.00163	CcSEcCtD
Candesartan—Angioedema—Methylprednisolone—ulcerative colitis	0.000138	0.00163	CcSEcCtD
Candesartan—Haemorrhage—Prednisone—ulcerative colitis	0.000137	0.00163	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000137	0.00722	CbGpPWpGaD
Candesartan—Myalgia—Hydrocortisone—ulcerative colitis	0.000136	0.00162	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000136	0.0072	CbGpPWpGaD
Candesartan—Anxiety—Hydrocortisone—ulcerative colitis	0.000136	0.00161	CcSEcCtD
Candesartan—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	0.000136	0.00718	CbGpPWpGaD
Candesartan—Vertigo—Triamcinolone—ulcerative colitis	0.000136	0.00161	CcSEcCtD
Candesartan—Vertigo—Methylprednisolone—ulcerative colitis	0.000135	0.00161	CcSEcCtD
Candesartan—Nausea—Budesonide—ulcerative colitis	0.000134	0.00159	CcSEcCtD
Candesartan—Dizziness—Azathioprine—ulcerative colitis	0.000134	0.00158	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000133	0.00705	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000133	0.00702	CbGpPWpGaD
Candesartan—Asthenia—Mesalazine—ulcerative colitis	0.000132	0.00157	CcSEcCtD
Candesartan—Cough—Triamcinolone—ulcerative colitis	0.000132	0.00156	CcSEcCtD
Candesartan—Tachycardia—Prednisolone—ulcerative colitis	0.000131	0.00155	CcSEcCtD
Candesartan—Hypertension—Triamcinolone—ulcerative colitis	0.00013	0.00155	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—PTGS1—ulcerative colitis	0.00013	0.00688	CbGpPWpGaD
Candesartan—Pruritus—Mesalazine—ulcerative colitis	0.00013	0.00154	CcSEcCtD
Candesartan—Hypertension—Methylprednisolone—ulcerative colitis	0.00013	0.00154	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000129	0.00154	CcSEcCtD
Candesartan—Myalgia—Triamcinolone—ulcerative colitis	0.000128	0.00152	CcSEcCtD
Candesartan—Vomiting—Azathioprine—ulcerative colitis	0.000128	0.00152	CcSEcCtD
Candesartan—Arthralgia—Methylprednisolone—ulcerative colitis	0.000128	0.00152	CcSEcCtD
Candesartan—Myalgia—Methylprednisolone—ulcerative colitis	0.000128	0.00152	CcSEcCtD
Candesartan—Anxiety—Methylprednisolone—ulcerative colitis	0.000128	0.00152	CcSEcCtD
Candesartan—Tachycardia—Hydrocortisone—ulcerative colitis	0.000128	0.00151	CcSEcCtD
Candesartan—Rash—Azathioprine—ulcerative colitis	0.000127	0.00151	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000127	0.00673	CbGpPWpGaD
Candesartan—Dermatitis—Azathioprine—ulcerative colitis	0.000127	0.00151	CcSEcCtD
Candesartan—Headache—Azathioprine—ulcerative colitis	0.000127	0.0015	CcSEcCtD
Candesartan—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000126	0.0015	CcSEcCtD
Candesartan—Diarrhoea—Mesalazine—ulcerative colitis	0.000126	0.00149	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.000126	0.00664	CbGpPWpGaD
Candesartan—Angioedema—Betamethasone—ulcerative colitis	0.000125	0.00148	CcSEcCtD
Candesartan—Angioedema—Dexamethasone—ulcerative colitis	0.000125	0.00148	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000125	0.00659	CbGpPWpGaD
Candesartan—Vertigo—Betamethasone—ulcerative colitis	0.000123	0.00146	CcSEcCtD
Candesartan—Vertigo—Dexamethasone—ulcerative colitis	0.000123	0.00146	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000122	0.00647	CbGpPWpGaD
Candesartan—Hypotension—Hydrocortisone—ulcerative colitis	0.000122	0.00145	CcSEcCtD
Candesartan—Dizziness—Mesalazine—ulcerative colitis	0.000122	0.00144	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000121	0.00638	CbGpPWpGaD
Candesartan—Paraesthesia—Prednisolone—ulcerative colitis	0.00012	0.00143	CcSEcCtD
Candesartan—Tachycardia—Triamcinolone—ulcerative colitis	0.00012	0.00143	CcSEcCtD
Candesartan—Mental disorder—Prednisone—ulcerative colitis	0.00012	0.00142	CcSEcCtD
Candesartan—Nausea—Azathioprine—ulcerative colitis	0.00012	0.00142	CcSEcCtD
Candesartan—Tachycardia—Methylprednisolone—ulcerative colitis	0.00012	0.00142	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00012	0.00634	CbGpPWpGaD
Candesartan—Malnutrition—Prednisone—ulcerative colitis	0.000119	0.00142	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000119	0.00141	CcSEcCtD
Candesartan—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000119	0.00141	CcSEcCtD
Candesartan—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000119	0.00141	CcSEcCtD
Candesartan—Hypertension—Betamethasone—ulcerative colitis	0.000118	0.0014	CcSEcCtD
Candesartan—Hypertension—Dexamethasone—ulcerative colitis	0.000118	0.0014	CcSEcCtD
Candesartan—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000117	0.00139	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000117	0.0062	CbGpPWpGaD
Candesartan—Vomiting—Mesalazine—ulcerative colitis	0.000117	0.00139	CcSEcCtD
Candesartan—Myalgia—Betamethasone—ulcerative colitis	0.000117	0.00138	CcSEcCtD
Candesartan—Myalgia—Dexamethasone—ulcerative colitis	0.000117	0.00138	CcSEcCtD
Candesartan—Anxiety—Dexamethasone—ulcerative colitis	0.000116	0.00138	CcSEcCtD
Candesartan—Anxiety—Betamethasone—ulcerative colitis	0.000116	0.00138	CcSEcCtD
Candesartan—Rash—Mesalazine—ulcerative colitis	0.000116	0.00138	CcSEcCtD
Candesartan—Dermatitis—Mesalazine—ulcerative colitis	0.000116	0.00137	CcSEcCtD
Candesartan—Headache—Mesalazine—ulcerative colitis	0.000115	0.00137	CcSEcCtD
Candesartan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000115	0.00137	CcSEcCtD
Candesartan—Hypotension—Methylprednisolone—ulcerative colitis	0.000115	0.00136	CcSEcCtD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	0.000114	0.00601	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000113	0.00134	CcSEcCtD
Candesartan—Fatigue—Hydrocortisone—ulcerative colitis	0.000113	0.00134	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000112	0.00133	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000112	0.00133	CcSEcCtD
Candesartan—Paraesthesia—Triamcinolone—ulcerative colitis	0.000111	0.00131	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	0.000111	0.00585	CbGpPWpGaD
Candesartan—Paraesthesia—Methylprednisolone—ulcerative colitis	0.00011	0.00131	CcSEcCtD
Candesartan—Anaemia—Prednisone—ulcerative colitis	0.00011	0.00131	CcSEcCtD
Candesartan—Dyspnoea—Triamcinolone—ulcerative colitis	0.00011	0.0013	CcSEcCtD
Candesartan—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000109	0.0013	CcSEcCtD
Candesartan—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000109	0.0013	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000109	0.00578	CbGpPWpGaD
Candesartan—Nausea—Mesalazine—ulcerative colitis	0.000109	0.0013	CcSEcCtD
Candesartan—Tachycardia—Dexamethasone—ulcerative colitis	0.000109	0.00129	CcSEcCtD
Candesartan—Tachycardia—Betamethasone—ulcerative colitis	0.000109	0.00129	CcSEcCtD
Candesartan—Angioedema—Prednisone—ulcerative colitis	0.000109	0.00129	CcSEcCtD
Candesartan—Dyspepsia—Triamcinolone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Candesartan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000108	0.00128	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000108	0.00128	CcSEcCtD
Candesartan—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000108	0.00128	CcSEcCtD
Candesartan—Vertigo—Prednisone—ulcerative colitis	0.000107	0.00127	CcSEcCtD
Candesartan—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000107	0.00127	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000107	0.00565	CbGpPWpGaD
Candesartan—Urticaria—Prednisolone—ulcerative colitis	0.000106	0.00126	CcSEcCtD
Candesartan—Fatigue—Triamcinolone—ulcerative colitis	0.000106	0.00126	CcSEcCtD
Candesartan—Fatigue—Methylprednisolone—ulcerative colitis	0.000106	0.00126	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000106	0.00558	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IFNG—ulcerative colitis	0.000105	0.00554	CbGpPWpGaD
Candesartan—Hypotension—Dexamethasone—ulcerative colitis	0.000104	0.00124	CcSEcCtD
Candesartan—Hypotension—Betamethasone—ulcerative colitis	0.000104	0.00124	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000104	0.0055	CbGpPWpGaD
Candesartan—Urticaria—Hydrocortisone—ulcerative colitis	0.000104	0.00123	CcSEcCtD
Candesartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000104	0.00548	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000104	0.00548	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000104	0.00548	CbGpPWpGaD
Candesartan—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000103	0.00123	CcSEcCtD
Candesartan—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000103	0.00123	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000103	0.00546	CbGpPWpGaD
Candesartan—Hypertension—Prednisone—ulcerative colitis	0.000103	0.00122	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000102	0.00121	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000102	0.00121	CcSEcCtD
Candesartan—Myalgia—Prednisone—ulcerative colitis	0.000102	0.0012	CcSEcCtD
Candesartan—Arthralgia—Prednisone—ulcerative colitis	0.000102	0.0012	CcSEcCtD
Candesartan—Anxiety—Prednisone—ulcerative colitis	0.000101	0.0012	CcSEcCtD
Candesartan—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.0001	0.00119	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.0001	0.00531	CbGpPWpGaD
Candesartan—Paraesthesia—Dexamethasone—ulcerative colitis	0.0001	0.00119	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—ulcerative colitis	0.0001	0.00119	CcSEcCtD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	9.97e-05	0.00527	CbGpPWpGaD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	9.88e-05	0.00522	CbGpPWpGaD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	9.86e-05	0.00521	CbGpPWpGaD
Candesartan—Dyspepsia—Dexamethasone—ulcerative colitis	9.84e-05	0.00117	CcSEcCtD
Candesartan—Dyspepsia—Betamethasone—ulcerative colitis	9.84e-05	0.00117	CcSEcCtD
Candesartan—Urticaria—Triamcinolone—ulcerative colitis	9.78e-05	0.00116	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	9.78e-05	0.00517	CbGpPWpGaD
Candesartan—Urticaria—Methylprednisolone—ulcerative colitis	9.76e-05	0.00116	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—CXCL8—ulcerative colitis	9.74e-05	0.00515	CbGpPWpGaD
Candesartan—Body temperature increased—Triamcinolone—ulcerative colitis	9.74e-05	0.00116	CcSEcCtD
Candesartan—Abdominal pain—Methylprednisolone—ulcerative colitis	9.72e-05	0.00115	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	9.68e-05	0.00512	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.65e-05	0.00114	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.65e-05	0.00114	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—ulcerative colitis	9.64e-05	0.00114	CcSEcCtD
Candesartan—Fatigue—Betamethasone—ulcerative colitis	9.64e-05	0.00114	CcSEcCtD
Candesartan—Tachycardia—Prednisone—ulcerative colitis	9.5e-05	0.00113	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—ulcerative colitis	9.41e-05	0.00112	CcSEcCtD
Candesartan—Asthenia—Hydrocortisone—ulcerative colitis	9.39e-05	0.00111	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL1B—ulcerative colitis	9.34e-05	0.00494	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—IL2—ulcerative colitis	9.31e-05	0.00492	CbGpPWpGaD
Candesartan—Pruritus—Hydrocortisone—ulcerative colitis	9.25e-05	0.0011	CcSEcCtD
Candesartan—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.14e-05	0.00108	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.14e-05	0.00108	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CCL20—ulcerative colitis	9.13e-05	0.00483	CbGpPWpGaD
Candesartan—Diarrhoea—Hydrocortisone—ulcerative colitis	8.95e-05	0.00106	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	8.92e-05	0.00472	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.92e-05	0.00472	CbGpPWpGaD
Candesartan—Urticaria—Betamethasone—ulcerative colitis	8.88e-05	0.00105	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—ulcerative colitis	8.88e-05	0.00105	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—ulcerative colitis	8.87e-05	0.00105	CcSEcCtD
Candesartan—Dizziness—Prednisolone—ulcerative colitis	8.86e-05	0.00105	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	8.85e-05	0.00468	CbGpPWpGaD
Candesartan—Asthenia—Triamcinolone—ulcerative colitis	8.84e-05	0.00105	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—ulcerative colitis	8.83e-05	0.00105	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—ulcerative colitis	8.83e-05	0.00105	CcSEcCtD
Candesartan—Abdominal pain—Betamethasone—ulcerative colitis	8.83e-05	0.00105	CcSEcCtD
Candesartan—Abdominal pain—Dexamethasone—ulcerative colitis	8.83e-05	0.00105	CcSEcCtD
Candesartan—Asthenia—Methylprednisolone—ulcerative colitis	8.82e-05	0.00105	CcSEcCtD
Candesartan—Paraesthesia—Prednisone—ulcerative colitis	8.74e-05	0.00104	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—ulcerative colitis	8.71e-05	0.00103	CcSEcCtD
Candesartan—Pruritus—Methylprednisolone—ulcerative colitis	8.69e-05	0.00103	CcSEcCtD
Candesartan—Dizziness—Hydrocortisone—ulcerative colitis	8.65e-05	0.00103	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—ulcerative colitis	8.57e-05	0.00102	CcSEcCtD
Candesartan—Rash—Prednisolone—ulcerative colitis	8.44e-05	0.001	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—ulcerative colitis	8.44e-05	0.001	CcSEcCtD
Candesartan—Diarrhoea—Methylprednisolone—ulcerative colitis	8.41e-05	0.000998	CcSEcCtD
Candesartan—Fatigue—Prednisone—ulcerative colitis	8.39e-05	0.000996	CcSEcCtD
Candesartan—Headache—Prednisolone—ulcerative colitis	8.39e-05	0.000996	CcSEcCtD
Candesartan—Losartan—ALB—ulcerative colitis	8.33e-05	0.0139	CrCbGaD
Candesartan—Vomiting—Hydrocortisone—ulcerative colitis	8.32e-05	0.000987	CcSEcCtD
Candesartan—Rash—Hydrocortisone—ulcerative colitis	8.25e-05	0.000979	CcSEcCtD
Candesartan—Dermatitis—Hydrocortisone—ulcerative colitis	8.24e-05	0.000978	CcSEcCtD
Candesartan—Headache—Hydrocortisone—ulcerative colitis	8.19e-05	0.000972	CcSEcCtD
Candesartan—Dizziness—Triamcinolone—ulcerative colitis	8.15e-05	0.000966	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CXCR2—ulcerative colitis	8.14e-05	0.0043	CbGpPWpGaD
Candesartan—Dizziness—Methylprednisolone—ulcerative colitis	8.13e-05	0.000964	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	8.11e-05	0.00429	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	8.1e-05	0.00428	CbGpPWpGaD
Candesartan—Asthenia—Dexamethasone—ulcerative colitis	8.02e-05	0.000951	CcSEcCtD
Candesartan—Asthenia—Betamethasone—ulcerative colitis	8.02e-05	0.000951	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—ulcerative colitis	7.96e-05	0.000944	CcSEcCtD
Candesartan—Nausea—Prednisolone—ulcerative colitis	7.96e-05	0.000944	CcSEcCtD
Candesartan—Losartan—ABCB1—ulcerative colitis	7.95e-05	0.0133	CrCbGaD
Candesartan—Pruritus—Betamethasone—ulcerative colitis	7.91e-05	0.000938	CcSEcCtD
Candesartan—Pruritus—Dexamethasone—ulcerative colitis	7.91e-05	0.000938	CcSEcCtD
Candesartan—Vomiting—Triamcinolone—ulcerative colitis	7.83e-05	0.000929	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	7.83e-05	0.00414	CbGpPWpGaD
Candesartan—Vomiting—Methylprednisolone—ulcerative colitis	7.81e-05	0.000927	CcSEcCtD
Candesartan—Nausea—Hydrocortisone—ulcerative colitis	7.77e-05	0.000922	CcSEcCtD
Candesartan—Rash—Triamcinolone—ulcerative colitis	7.77e-05	0.000921	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—ulcerative colitis	7.76e-05	0.000921	CcSEcCtD
Candesartan—Rash—Methylprednisolone—ulcerative colitis	7.75e-05	0.000919	CcSEcCtD
Candesartan—Dermatitis—Methylprednisolone—ulcerative colitis	7.74e-05	0.000919	CcSEcCtD
Candesartan—Urticaria—Prednisone—ulcerative colitis	7.73e-05	0.000917	CcSEcCtD
Candesartan—Headache—Triamcinolone—ulcerative colitis	7.72e-05	0.000916	CcSEcCtD
Candesartan—Headache—Methylprednisolone—ulcerative colitis	7.7e-05	0.000914	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—ulcerative colitis	7.69e-05	0.000913	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—ulcerative colitis	7.69e-05	0.000913	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	7.69e-05	0.00407	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CCR6—ulcerative colitis	7.65e-05	0.00405	CbGpPWpGaD
Candesartan—Diarrhoea—Betamethasone—ulcerative colitis	7.65e-05	0.000907	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—ulcerative colitis	7.65e-05	0.000907	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	7.55e-05	0.00399	CbGpPWpGaD
Candesartan—Dizziness—Dexamethasone—ulcerative colitis	7.39e-05	0.000877	CcSEcCtD
Candesartan—Dizziness—Betamethasone—ulcerative colitis	7.39e-05	0.000877	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.36e-05	0.00389	CbGpPWpGaD
Candesartan—Nausea—Triamcinolone—ulcerative colitis	7.32e-05	0.000868	CcSEcCtD
Candesartan—Nausea—Methylprednisolone—ulcerative colitis	7.3e-05	0.000866	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TGFB1—ulcerative colitis	7.26e-05	0.00384	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.26e-05	0.00384	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	7.17e-05	0.00379	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	7.15e-05	0.00378	CbGpPWpGaD
Candesartan—Vomiting—Dexamethasone—ulcerative colitis	7.11e-05	0.000843	CcSEcCtD
Candesartan—Vomiting—Betamethasone—ulcerative colitis	7.11e-05	0.000843	CcSEcCtD
Candesartan—Rash—Dexamethasone—ulcerative colitis	7.05e-05	0.000836	CcSEcCtD
Candesartan—Rash—Betamethasone—ulcerative colitis	7.05e-05	0.000836	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—ulcerative colitis	7.04e-05	0.000835	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—ulcerative colitis	7.04e-05	0.000835	CcSEcCtD
Candesartan—Headache—Dexamethasone—ulcerative colitis	7e-05	0.000831	CcSEcCtD
Candesartan—Headache—Betamethasone—ulcerative colitis	7e-05	0.000831	CcSEcCtD
Candesartan—Asthenia—Prednisone—ulcerative colitis	6.98e-05	0.000829	CcSEcCtD
Candesartan—Pruritus—Prednisone—ulcerative colitis	6.89e-05	0.000817	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.87e-05	0.00363	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—ulcerative colitis	6.78e-05	0.00358	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—PTGER4—ulcerative colitis	6.74e-05	0.00356	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	6.72e-05	0.00355	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	6.7e-05	0.00354	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—ulcerative colitis	6.66e-05	0.00079	CcSEcCtD
Candesartan—Nausea—Dexamethasone—ulcerative colitis	6.64e-05	0.000788	CcSEcCtD
Candesartan—Nausea—Betamethasone—ulcerative colitis	6.64e-05	0.000788	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.59e-05	0.00348	CbGpPWpGaD
Candesartan—Dizziness—Prednisone—ulcerative colitis	6.44e-05	0.000764	CcSEcCtD
Candesartan—Vomiting—Prednisone—ulcerative colitis	6.19e-05	0.000734	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—GHRL—ulcerative colitis	6.17e-05	0.00326	CbGpPWpGaD
Candesartan—Rash—Prednisone—ulcerative colitis	6.14e-05	0.000728	CcSEcCtD
Candesartan—Dermatitis—Prednisone—ulcerative colitis	6.13e-05	0.000727	CcSEcCtD
Candesartan—Headache—Prednisone—ulcerative colitis	6.1e-05	0.000723	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	5.92e-05	0.00313	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	5.88e-05	0.00311	CbGpPWpGaD
Candesartan—Nausea—Prednisone—ulcerative colitis	5.78e-05	0.000686	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	5.49e-05	0.0029	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR1—ulcerative colitis	5.34e-05	0.00282	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CHP1—ulcerative colitis	5.34e-05	0.00282	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—ulcerative colitis	5.23e-05	0.00276	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCL20—ulcerative colitis	5.16e-05	0.00273	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—ADRB2—ulcerative colitis	5.11e-05	0.0027	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.01e-05	0.00265	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5e-05	0.00264	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	4.95e-05	0.00261	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.88e-05	0.00258	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GNA12—ulcerative colitis	4.85e-05	0.00256	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	4.83e-05	0.00255	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	4.81e-05	0.00254	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	4.79e-05	0.00253	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	4.74e-05	0.0025	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL20—ulcerative colitis	4.69e-05	0.00248	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—DLD—ulcerative colitis	4.61e-05	0.00244	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	4.6e-05	0.00243	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.47e-05	0.00236	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GNA12—ulcerative colitis	4.41e-05	0.00233	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CCR6—ulcerative colitis	4.32e-05	0.00229	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	4.26e-05	0.00225	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	4.21e-05	0.00223	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCR2—ulcerative colitis	4.18e-05	0.00221	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.17e-05	0.0022	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—ulcerative colitis	4.11e-05	0.00217	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.97e-05	0.0021	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCR6—ulcerative colitis	3.93e-05	0.00208	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3.86e-05	0.00204	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SEL1L—ulcerative colitis	3.83e-05	0.00202	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	3.81e-05	0.00201	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GHRL—ulcerative colitis	3.49e-05	0.00184	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTGER4—ulcerative colitis	3.46e-05	0.00183	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	3.24e-05	0.00171	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.24e-05	0.00171	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GHRL—ulcerative colitis	3.17e-05	0.00167	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR1—ulcerative colitis	3.15e-05	0.00167	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.07e-05	0.00163	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CALM3—ulcerative colitis	3.07e-05	0.00162	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CHP1—ulcerative colitis	3.01e-05	0.00159	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.94e-05	0.00156	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.94e-05	0.00156	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.89e-05	0.00153	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	2.86e-05	0.00151	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL20—ulcerative colitis	2.77e-05	0.00146	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	2.74e-05	0.00145	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—ulcerative colitis	2.73e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADRB2—ulcerative colitis	2.62e-05	0.00139	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.62e-05	0.00138	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GNA12—ulcerative colitis	2.6e-05	0.00138	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—DLD—ulcerative colitis	2.59e-05	0.00137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR2—ulcerative colitis	2.47e-05	0.0013	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—ulcerative colitis	2.47e-05	0.0013	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.46e-05	0.0013	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.45e-05	0.00129	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR6—ulcerative colitis	2.32e-05	0.00123	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS1—ulcerative colitis	2.23e-05	0.00118	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADCY5—ulcerative colitis	2.22e-05	0.00118	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAML2—ulcerative colitis	2.2e-05	0.00116	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.13e-05	0.00113	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTGER4—ulcerative colitis	2.04e-05	0.00108	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CALM3—ulcerative colitis	2.01e-05	0.00106	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—ulcerative colitis	1.99e-05	0.00105	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.94e-05	0.00103	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GHRL—ulcerative colitis	1.87e-05	0.000988	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.83e-05	0.000969	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.82e-05	0.000962	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CALM3—ulcerative colitis	1.81e-05	0.000957	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RIPK2—ulcerative colitis	1.78e-05	0.000943	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CHP1—ulcerative colitis	1.69e-05	0.000894	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—DLD—ulcerative colitis	1.68e-05	0.000886	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.58e-05	0.000835	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCB1—ulcerative colitis	1.56e-05	0.000824	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADRB2—ulcerative colitis	1.55e-05	0.000818	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—JAK2—ulcerative colitis	1.53e-05	0.000807	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.48e-05	0.000783	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—DLD—ulcerative colitis	1.46e-05	0.000772	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ADCY5—ulcerative colitis	1.45e-05	0.000769	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.45e-05	0.000769	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.39e-05	0.000737	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—JAK2—ulcerative colitis	1.39e-05	0.000733	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.37e-05	0.000725	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—DLD—ulcerative colitis	1.36e-05	0.000721	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—ulcerative colitis	1.33e-05	0.000704	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADCY5—ulcerative colitis	1.31e-05	0.000695	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—ulcerative colitis	1.27e-05	0.000669	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.26e-05	0.000667	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.23e-05	0.000652	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—ulcerative colitis	1.21e-05	0.000639	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CALM3—ulcerative colitis	1.13e-05	0.000597	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—ulcerative colitis	1.08e-05	0.000574	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.08e-05	0.000571	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.05e-05	0.000556	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.84e-06	0.00052	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.82e-06	0.000519	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—ulcerative colitis	9.76e-06	0.000516	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.86e-06	0.000469	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—ulcerative colitis	8.78e-06	0.000464	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.66e-06	0.000458	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—ulcerative colitis	8.53e-06	0.000451	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ADCY5—ulcerative colitis	8.19e-06	0.000433	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAK2—ulcerative colitis	8.19e-06	0.000433	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS1—ulcerative colitis	8.1e-06	0.000428	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.97e-06	0.000421	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RELA—ulcerative colitis	7.93e-06	0.000419	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—ulcerative colitis	7.47e-06	0.000395	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CALM3—ulcerative colitis	7.3e-06	0.000386	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.21e-06	0.000381	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—ulcerative colitis	7.14e-06	0.000378	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—ulcerative colitis	7.11e-06	0.000376	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS1—ulcerative colitis	7.06e-06	0.000373	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.97e-06	0.000369	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—ulcerative colitis	6.76e-06	0.000357	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKB1—ulcerative colitis	6.69e-06	0.000354	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.6e-06	0.000349	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS1—ulcerative colitis	6.59e-06	0.000349	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.49e-06	0.000343	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CALM3—ulcerative colitis	6.36e-06	0.000336	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—ulcerative colitis	6.11e-06	0.000323	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—ulcerative colitis	6.01e-06	0.000318	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.94e-06	0.000314	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.67e-06	0.0003	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.67e-06	0.0003	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—ulcerative colitis	5.57e-06	0.000295	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—ulcerative colitis	5.49e-06	0.00029	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADCY5—ulcerative colitis	5.29e-06	0.00028	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—ulcerative colitis	4.81e-06	0.000254	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.62e-06	0.000244	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.61e-06	0.000244	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—ulcerative colitis	4.59e-06	0.000243	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADCY5—ulcerative colitis	4.31e-06	0.000228	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—ulcerative colitis	4.2e-06	0.000222	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.95e-06	0.000209	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—ulcerative colitis	3.55e-06	0.000188	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—ulcerative colitis	3.44e-06	0.000182	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—ulcerative colitis	3.21e-06	0.00017	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—ulcerative colitis	3.11e-06	0.000164	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—ulcerative colitis	3.09e-06	0.000163	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—ulcerative colitis	2.89e-06	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.71e-06	0.000143	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.53e-06	0.000134	CbGpPWpGaD
